Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

GSK files for Japanese approval of oral kinase inhibitor in malignant soft tissue sarcoma

Dec. 16, 2011

Threshold reports encouraging results from ongoing TH-302 trial in advanced leukemias

Dec. 16, 2011

PARP inhibitor shows promise combined with temozolomide in advanced solid tumors

Dec. 16, 2011

PANORAMA 1 study evaluates panobinostat in multiple myeloma

Dec. 16, 2011

Novel protein kinase inhibitors reported

Dec. 16, 2011

Zybrestat to be provided on a compassionate-use basis

Dec. 15, 2011

Avila Therapeutics product shows promise to treat hematological cancers

Dec. 15, 2011

OSI Pharmaceuticals presents new macrophage-stimulating protein receptor inhibitors

Dec. 15, 2011

Researchers at Chemilia design new anticancer agents

Dec. 15, 2011

Antitumor effects of K-560 evaluated in preclinical settings

Dec. 15, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...